SEC Form 4 · accession 0001013606-18-000075
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Director
Period of report
May 10, 2018
Accepted (ET)
May 14, 2018 · 6:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 10, 2018 | M | 177,065 | $2.67 | A | 1,020,212 | D | |
| Common Stock | May 10, 2018 | F | 133,503 | $4.73 | D | 886,709 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase | $2.67 | May 10, 2018 | M | 177,065 | D | May 12, 2009 | May 12, 2018 | Common Stock | 177,065 | 0 | D |
Explanation of responses
- F1Represents a "net exercise" of outstanding stock options. The reporting person received 43,562 shares of common stock upon the net exercise of options to purchase 177,065 shares of common stock, with 133,503 shares withheld for payment of taxes and the exercise price, based on the market price of Issuer's common stock at the time of the option exercise.
Remarks
Total shares owned includes 4,488 shares purchased through the Company's Employee Stock Purchase Plan on April 30, 2018 and have not previously been disclosed due to immateriality.